Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Abivertinib |
Trade Name | |
Synonyms | Avitinib|AC0010|AC0010MA |
Drug Descriptions |
Abivertinib (AC0010) is a BTK inhibitor and a third-generation EGFR inhibitor that blocks the activity of mutant forms of EGFR while sparing wild-type EGFR, which potentially results in increased apoptosis and cell cycle arrest, and decreased viability and colony formation, and inhibits tumor growth (PMID: 27573423, PMID: 31310800). |
DrugClasses | BTK inhibitor 37 EGFR Inhibitor 3rd gen 26 |
CAS Registry Number | 1557267-42-1 |
NCIT ID | C147125 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abiraterone + Abivertinib | Abiraterone Abivertinib | 0 | 1 |
Abivertinib | Abivertinib | 1 | 1 |
Abivertinib + Omacetaxine mepesuccinate | Abivertinib Omacetaxine mepesuccinate | 1 | 0 |